Veteran Healthcare Executive and Reimbursement Expert Joins InterVenn Biosciences’ Board of Advisors
James Almas, MD, has joined the company’s Board of Advisors to advise on reimbursement strategy, health economics, coding, and other foundational activities required for commercialization of novel diagnostic tests for the clinical market.